Advisory: Alert from FN Media Group wrongly tagged to multiple companies withdrawn
17/06/2024 14:56
An alert on FN Media Group's Acute Myeloid Leukemia market
report was inadvertently tagged to Acutinium Pharmaceuticals
ATNM.A , Bio Path Holdings BPTH.O , Bristol-Myers Squibb
BMY.N , Sellas Life Sciences Group SLS.O and Longeveron
LGVN.O and has been withdrawn.
There will be no substitute.
STORY_NUMBER: urn:newsml:reuters.com:*:nTUA1KRCHP
STORY_DATE: 17/06/2024
STORY_TIME:[01:45:02 PM GMT]
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Bio Path Holdings
See all newsBrief: Bio-Path Holdings Seeks Financing For Turnaround & Strategic Actions
Brief: Bio-Path Holdings Reports Full Year 2024 Financial Results
Brief: Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Brief: Bio-Path Provides Key Clinical Updates
Brief: Bio-Path Holdings Provides Update From Phase 1/1B Clinical Trial Of Bp1002 For Treatment Of Refractory/Relapsed Acute Myeloid Leukemia